University of Miami Law Students Fight Toxic Dumping

 

University of Miami Lawpic

University of Miami Law
Image: law.miami.edu

An accomplished investment executive, David Simon currently serves as the CEO and CIO of Twin Capital Management in New York City. In his work with Twin Capital, David Simon draws on extensive experience in the finance industry as well as a law degree from the University of Miami School of Law.

Since officially opening its doors in 1928, the University of Miami School of Law has trained generations of future leaders in the legal, political, and corporate worlds. Over the years, the school has emerged as a premier international center for legal education with a range of highly regarded programs including business and taxation law, intellectual property law, and environmental law.

The University of Miami environmental law program made headlines recently when its students helped expose illegal toxic dumping on Florida’s west coast. When a local reporter raised concerns about illegal dumping of lime sludge by the City of Fort Myers in the African-American community of Dunbar, students from the University of Miami environmental law clinic jumped on the case. They traveled to the community to meet with local residents and help them form a legal plan of action.

After hearing about the community’s concerns, the law students conducted extensive research and provided fact-finding services in concert with local attorneys who volunteered to take the case. Partly as a result of the students’ efforts, the attorneys filed a class-action lawsuit in the spring of 2018 against the City of Fort Myers that seeks damages for violating anti-dumping laws and the creation of a health care program to monitor residents for ill effects potentially caused by the toxic waste.

Advertisements

University of Miami Law Review 2018 Symposium

 

University of Miami Law Reviewpic

University of Miami Law Review
Image: lawreview.law.miami.edu

David Simon is the managing member and co-chief investment officer of Twin Capital Management, LLC. In preparation for his career, David Simon graduated magna cum laude from Muhlenberg College with a BS and from the University of Miami School of Law with a JD. While in law school, he served as a member of the law review.

Founded in 1947, the University of Miami Law Review is the oldest continuously published law review in the state of Florida. It publishes four issues per year featuring rigorously reviewed and edited articles of note for legal scholars and practitioners, and stands out for its annual issue analyzing the Eleventh Circuit Court of Appeals. In addition, the review coordinates an annual symposium each year.

The 2018 symposium, Hack to the Future, focused on how technology affects the legal profession. Held from February 9-10 at the University of Miami’s Donna E. Shalala Student Center, the symposium featured keynote speaker Hilarie Bass, a trial attorney and co-president of the law firm Greenberg Traurig. The symposium also hosted panels on special topics such as the legal aspects of artificial intelligence, data privacy and cybersecurity, and the role of technology increasing access to legal services.

The Michaels Companies Donates Starlight Gowns

 

Starlight Children's Foundation pic

Starlight Children’s Foundation
Image: starlight.org

A veteran investment professional with a background in risk arbitrage, David Simon currently serves as the managing member and co-chief investment officer of Twin Capital Management, LLC. Outside of his professional life, David Simon commits himself to a range of philanthropic initiatives that include overseeing his own foundation. For many years he also supported the Starlight Children’s Foundation, through which he co-founded an annual golf outing.

Since 1982, the Starlight Foundation has provided once-in-a-lifetime experiences to more than 60 million critically and terminally ill children across the United States, the United Kingdom, Canada, and Australia. As part of its commitment to bringing joy to children, the Starlight Children’s Foundation maintains a series of programs, including its Starlight Gowns initiative.

Inspired by a similar effort by Brave Gowns, Starlight Gowns provides hospitalized children with beautiful and comfortable hospital gowns as a replacement for the uncomfortable and plain hospital garb that is typically issued. The gowns take the form of astronaut suits, princess dresses, and other magical costumes, bringing joy into what is often a frightening and anxiety-producing hospital stay.

In November 2017, the Starlight Children’s Foundation announced that The Michaels Companies, which operates thousands of arts and crafts stores across North America, had sponsored 10,000 Starlight Gowns to distribute to hospitalized children. As part of the contribution, designers with Michaels created 10 unique designs featuring explorers, scuba divers, and more.

Oncolytic Virus Therapy Now in Phase 1 Clinical Trial Among Children

 

Solving Kids' Cancerpic

Solving Kids’ Cancer
Image: solvingkidscancer.org

In 1988, David Simon founded Twin Capital Management, LLC, a company based in New York, New York, and is currently the firm’s Co-Chief investment officer. Outside of his business commitment to overseeing Twin Capital, David Simon supports different charitable organizations such as Solving Kids’ Cancer.

New York-based organization Solving Kids’ Cancer focuses on helping develop treatments for aggressive childhood cancers with low survival rates. Through the years, the organization has been instrumental in the creation of effective treatments to combat childhood cancer through clinical trials and research.

One of their treatments involves a brain cancer therapy that has just recently been made available to children with high-grade brain tumors. In 2017, the oncolytic virus therapy in adults was made available to children in phase 1 clinical trials. Co-funded by the Andrew McDonough B+ Foundation, the treatment is given to children aged 0-15 years old with recurrent high-grade gliomas. The PVS-RIPO poliovirus is delivered to the tumor using convection-enhanced delivery, an emerging technology that delivers agents to the tumors in the brain using a small catheter.